From Functional Genomics to Functional Immunomics: New Challenges, Old Problems, Big Rewards

Overview

Journal PLoS Comput Biol

Specialty Biology

Date 2006 Jul 26

PMID 16863395

Citations 23

Authors

Ulisses M Braga-Neto

Ernesto T A Marques Jr

Affiliations

Soon will be listed here.

Abstract

The development of DNA microarray technology a decade ago led to the establishment of functional genomics as one of the most active and successful scientific disciplines today. With the ongoing development of immunomic microarray technology-a spatially addressable, large-scale technology for measurement of specific immunological response-the new challenge of functional immunomics is emerging, which bears similarities to but is also significantly different from functional genomics. Immunonic data has been successfully used to identify biological markers involved in autoimmune diseases, allergies, viral infections such as human immunodeficiency virus (HIV), influenza, diabetes, and responses to cancer vaccines. This review intends to provide a coherent vision of this nascent scientific field, and speculate on future research directions. We discuss at some length issues such as epitope prediction, immunomic microarray technology and its applications, and computation and statistical challenges related to functional immunomics. Based on the recent discovery of regulation mechanisms in T cell responses, we envision the use of immunomic microarrays as a tool for advances in systems biology of cellular immune responses, by means of immunomic regulatory network models.

Citing Articles

Lymphocyte infiltration in breast cancer: A promising prognostic indicator.

Obeagu E, Obeagu G Medicine (Baltimore). 2024; 103(49):e40845.

PMID: 39654199 PMC: 11631027. DOI: 10.1097/MD.0000000000040845.

Systems neuroimmunology: a review of multiomics methodologies to characterize neuroimmunological interactions in spinal and cranial diseases.

Zamanian C, Bhandarkar A, Monie D, Moinuddin F, Vile R, Quinones-Hinojosa A Neurosurg Focus. 2022; 52(2):E9.

PMID: 35104798 PMC: 9011195. DOI: 10.3171/2021.11.FOCUS21571.

Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.

Goudsmit J, van den Biggelaar A, Koudstaal W, Hofman A, Koff W, Schenkelberg T Eur J Epidemiol. 2021; 36(7):753-762.

PMID: 34117979 PMC: 8196271. DOI: 10.1007/s10654-021-00767-z.

Skin microbiome of coral reef fish is highly variable and driven by host phylogeny and diet.

Chiarello M, Auguet J, Bettarel Y, Bouvier C, Claverie T, Graham N Microbiome. 2018; 6(1):147.

PMID: 30143055 PMC: 6109317. DOI: 10.1186/s40168-018-0530-4.

Omics Approaches for the Study of Adaptive Immunity to and the Selection of Vaccine Candidates.

Holtfreter S, Kolata J, Stentzel S, Bauerfeind S, Schmidt F, Sundaramoorthy N Proteomes. 2017; 4(1).

PMID: 28248221 PMC: 5217363. DOI: 10.3390/proteomes4010011.

References

Wraith D, Nicolson K, Whitley N . Regulatory CD4+ T cells and the control of autoimmune disease. Curr Opin Immunol. 2004; 16(6):695-701. DOI: 10.1016/j.coi.2004.09.015. View

Schwenk J, Stoll D, Templin M, Joos T . Cell microarrays: an emerging technology for the characterization of antibodies. Biotechniques. 2003; Suppl:54-61. View

Pavlickova P, Knappik A, Kambhampati D, Ortigao F, Hug H . Microarray of recombinant antibodies using a streptavidin sensor surface self-assembled onto a gold layer. Biotechniques. 2003; 34(1):124-30. DOI: 10.2144/03341rr03. View

Lee S, Williamson B, Caballero O, Chen Y, Scanlan M, Ritter G . Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer Immun. 2004; 4:13. View

Varnum S, Woodbury R, Zangar R . A protein microarray ELISA for screening biological fluids. Methods Mol Biol. 2004; 264:161-72. DOI: 10.1385/1-59259-759-9:161. View

Reineke U, Ivascu C, Schlief M, Landgraf C, Gericke S, Zahn G . Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences. J Immunol Methods. 2002; 267(1):37-51. DOI: 10.1016/s0022-1759(02)00139-4. View

De Groot A . Immunome-derived vaccines. Expert Opin Biol Ther. 2004; 4(6):767-72. DOI: 10.1517/14712598.4.6.767. View

Balboni I, Chan S, Kattah M, Tenenbaum J, Butte A, Utz P . Multiplexed protein array platforms for analysis of autoimmune diseases. Annu Rev Immunol. 2006; 24:391-418. DOI: 10.1146/annurev.immunol.24.021605.090709. View

Bryant P, Venter D, Robins-Browne R, Curtis N . Chips with everything: DNA microarrays in infectious diseases. Lancet Infect Dis. 2004; 4(2):100-11. DOI: 10.1016/S1473-3099(04)00930-2. View

10.

Wang Y . Immunostaining with dissociable antibody microarrays. Proteomics. 2004; 4(1):20-6. DOI: 10.1002/pmic.200300549. View

11.

Janzi M, Odling J, Pan-Hammarstrom Q, Sundberg M, Lundeberg J, Uhlen M . Serum microarrays for large scale screening of protein levels. Mol Cell Proteomics. 2005; 4(12):1942-7. DOI: 10.1074/mcp.M500213-MCP200. View

12.

Alcocer M, Murtagh G, Wilson P, Progias P, Lin J, Archer D . The major human structural IgE epitope of the Brazil nut allergen Ber e 1: a chimaeric and protein microarray approach. J Mol Biol. 2004; 343(3):759-69. DOI: 10.1016/j.jmb.2004.08.065. View

13.

Pang S, Smith J, Onley D, Reeve J, Walker M, Foy C . A comparability study of the emerging protein array platforms with established ELISA procedures. J Immunol Methods. 2005; 302(1-2):1-12. DOI: 10.1016/j.jim.2005.04.007. View

14.

Brusic V, Petrovsky N, Zhang G, Bajic V . Prediction of promiscuous peptides that bind HLA class I molecules. Immunol Cell Biol. 2002; 80(3):280-5. DOI: 10.1046/j.1440-1711.2002.01088.x. View

15.

Quintana F, Getz G, Hed G, Domany E, Cohen I . Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: a bio-informatic approach to immune complexity. J Autoimmun. 2003; 21(1):65-75. DOI: 10.1016/s0896-8411(03)00064-7. View

16.

Chen Y, Dougherty E, Bittner M . Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomed Opt. 2012; 2(4):364-74. DOI: 10.1117/12.281504. View

17.

Mezzasoma L, Bacarese-Hamilton T, Di Cristina M, Rossi R, Bistoni F, Crisanti A . Antigen microarrays for serodiagnosis of infectious diseases. Clin Chem. 2001; 48(1):121-30. View

18.

Soen Y, Chen D, Kraft D, Davis M, Brown P . Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol. 2003; 1(3):E65. PMC: 300678. DOI: 10.1371/journal.pbio.0000065. View

19.

Schena M, Shalon D, Davis R, Brown P . Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995; 270(5235):467-70. DOI: 10.1126/science.270.5235.467. View

20.

Knezevic V, Leethanakul C, Bichsel V, Worth J, Prabhu V, Gutkind J . Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics. 2001; 1(10):1271-8. DOI: 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO;2-6. View